Item 1.01 Entry into a Material Definitive Agreement.

On February 5, 2021, our Chief Executive Officer, Mr. Kingrich Lee executed a Deed of Gift to irrevocably and unconditionally give, transfer and assign, by way of gift, without limitation or restriction, to Luckwel Pharmaceuticals, Inc. (the "Company") all of his right, title and interest in, arising from and to the following drug programs:





       Program Code Patent No.   Filing Date   Description

       LWEL-2101    63/086,205   Oct 5, 2020   Rapid Disintegrating dosage form
                                               comprising Fosamprenavir

       LWEL-2102    63/134,881   Jan 7, 2021   Rapid Distrintegrating dosage form
                                               comprising Metformin Hydrochloride

       LWEL-2103    62/992,693   March 20,2020 Combination Therapy for treating
                                               Covid-19

The foregoing description of the Deed of Gift does not purport to be complete and is qualified in its entirety by reference to the Deed of Gift, which is attached to this Current Report on Form 8-K as Exhibit 10.1.

© Edgar Online, source Glimpses